Nexalin Technology, INC. (NXL) SEC Filings — 2025

Filings

• Nexalin Technology, INC. 8-K Filing — 8-K · Dec 5, 2025
• Nexalin's Losses Widen Amid Revenue Dip, FDA Q-Sub Accepted — 10-Q · Nov 14, 2025
• Nexalin Technology Files 8-K — 8-K · Oct 15, 2025
• Nexalin Amends 10-K for Control Weaknesses, Refiles 2024 Financials — 10-K/A · Sep 23, 2025
• Nexalin Technology Files 8-K — 8-K · Sep 22, 2025
• Nexalin's Net Loss Widens 25% Amid Zero Revenue in Q2 — 10-Q · Aug 6, 2025
• Nexalin Technology Reports Officer Changes and Financials — 8-K · Aug 4, 2025
• Nexalin Technology Reports Officer/Director Changes & Compensatory Arrangements — 8-K · Jul 21, 2025
• Nexalin Technology Files 8-K on Shareholder Vote Matters — 8-K · Jul 17, 2025
• Nexalin Sets July 15 Virtual Shareholder Meeting for Director Elections, Equity Plan Vote — DEF 14A · Jun 17, 2025
• Nexalin Technology Files 8-K — 8-K · Jun 9, 2025
• Nexalin Technology Files Q1 2025 10-Q — 10-Q · May 13, 2025
• Nexalin Technology Files 8-K for Material Agreement — 8-K · May 6, 2025
• Nexalin Technology Files 8-K — 8-K · May 5, 2025
• Nexalin Technology Files 8-K: Accountant Change Reported — 8-K · Apr 17, 2025
• Nexalin Technology Files 2024 Annual Report Amendment — 10-K/A · Apr 15, 2025
• Nexalin Technology Files 2024 10-K — 10-K · Mar 14, 2025
• Nexalin Technology Files 8-K — 8-K · Feb 6, 2025
• Nexalin Technology Files S-1/A Amendment — S-1/A · Jan 30, 2025
• Nexalin Technology Files S-1/A Amendment — S-1/A · Jan 10, 2025